Basir, Lambaina .
HRN: 29-46-06 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/07/2026
CEFTRIAXONE 1G (VIAL)
08/07/2026
08/14/2026
IV
2G
Q24
CAP MR
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: